Tirzepatide 20mg — Research Peptide
LAB 101 Tirzepatide 20mg is a research peptide supplied for laboratory and scientific research applications. Tirzepatide is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist extensively studied in clinical and experimental research involving glucose metabolism, appetite regulation, energy balance, body-weight regulation and metabolic signalling pathways.
For researchers looking for Tirzepatide in Australia, LAB 101 Tirzepatide 20mg is supplied in lyophilised form with a focus on product transparency, consistency and batch documentation. All peptides are independently verified at ≥99% purity.
Product: Tirzepatide
Quantity: 20mg per vial
Form: Lyophilised powder
Research areas: GIP and GLP-1 receptor signalling, glucose metabolism, appetite regulation, energy balance, body-weight regulation and metabolic research
Location: Australia
Research Use Only: This product is supplied strictly for laboratory and scientific research purposes. It is not intended for human consumption, therapeutic use, injection or self-administration.
For laboratory and in-vitro research purposes only. Not intended for human or animal consumption, administration, diagnostic, therapeutic or veterinary use.
